Caplin Point Laboratories · NSE: CAPLIPOINT · BSE: 524742
Q1 FY20 results · Apr–Jun 2019
Caplin Point Laboratories reported revenue from operations of ₹192.55 crore and net profit of ₹50.07 crore for Q1 FY20 (Apr–Jun 2019), on a consolidated basis.
| Item | Q1 FY20 | Q1 FY19 | YoY | Q4 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 192.55 | — | — | 187.34 | +2.8% |
| Other income | 4.47 | — | — | 2.67 | +67.5% |
| Total income | 197.02 | — | — | 190.01 | +3.7% |
| Profit before tax | 64.45 | — | — | 60.69 | +6.2% |
| Net profit for the period | 50.07 | — | — | 49.86 | +0.4% |
| Attributable to shareholders of the company | 49.86 | — | — | 49.81 | +0.1% |
| EPS, basic (₹) | 6.64 | — | — | 6.58 | +0.9% |
| Net margin (%) | 26.0 | — | 26.6 |
| Item | Q1 FY20 | Q1 FY19 | YoY | Q4 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 140.27 | 125.16 | +12.1% | 140.74 | −0.3% |
| Other income | 19.94 | 18.05 | +10.5% | 3.31 | +501.7% |
| Total income | 160.21 | 143.22 | +11.9% | 144.06 | +11.2% |
| Profit before tax | 74.03 | 53.14 | +39.3% | 55.33 | +33.8% |
| Net profit for the period | 60.11 | 41.36 | +45.3% | 40.32 | +49.1% |
| EPS, basic (₹) | 7.95 | 0.00 | — | 5.34 | +48.9% |
| Net margin (%) | 42.9 | 33.0 | 28.7 |
Consolidated
- Filed with BSE
- 14 Aug 2019, 13:09 IST
- Board meeting
- 12 Aug 2019
- Period
- 01 Apr 2019 to 30 Jun 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 14 Aug 2019, 13:09 IST
- Board meeting
- 12 Aug 2019
- Period
- 01 Apr 2019 to 30 Jun 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE